Application of reagent for detecting intestinal flora in preparation of diffuse large B-cell lymphoma diagnosis or staging kit
By detecting the species abundance and interaction strength of gut microbiota, a diagnostic model for DLBCL was constructed, which solved the problem of the lack of non-invasive diagnostic tools in the existing technology, and realized the rapid and accurate diagnosis and staging of DLBCL, thus improving the efficiency of screening and prognosis.
Patent Information
- Application Number
- CN202610297321.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-12
- Publication Date
- 2026-04-10
AI Technical Summary
The lack of systematic research on gut microbiota in existing technologies for non-invasive diagnostic tools for diffuse large B-cell lymphoma (DLBCL) leads to problems of high invasiveness and low sensitivity in diagnosis and staging.
By using reagents to detect gut microbiota, particularly short-chain fatty acid-producing bacteria, Enterococcus species, Helicobacter species, yeast species, and pathogenic fungi, the species abundance and interaction strength of gut microbiota are analyzed, and a diagnostic model is constructed to achieve rapid diagnosis and staging of DLBCL.
It enables rapid, non-invasive auxiliary diagnosis of DLBCL, improves the early screening rate and the accuracy of prognosis, provides microbiome evidence, and has high sensitivity and specificity, making it suitable for large-scale screening and longitudinal disease monitoring.
Smart Images

Figure CN121826155A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biotechnology, specifically relating to the application of reagents for detecting gut microbiota in the preparation of diagnostic or staging kits for diffuse large B-cell lymphoma. Background Technology
[0002] Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. Its pathogenesis is complex and highly heterogeneous. Currently, diagnosis and staging mainly rely on imaging and tissue biopsy, which have problems such as high invasiveness and low sensitivity.
[0003] To address the aforementioned issues, Chinese invention patent application CN116622846A discloses that peripheral blood circRNA hsa_circ_0080018 can serve as a biomarker for the diagnosis of diffuse large B-cell lymphoma. ROC analysis revealed that hsa_circ_0080018 has superior diagnostic efficacy for diffuse large B-cell lymphoma (AUC=0.85).
[0004] For example, Chinese invention patent application CN120624639A discloses the role of six tsRNAs—tsRNA-Leu-CAG, tsRNA-Pro-CG, tsRNA-Gln-CTG, tsRNA-Cys-GCA, tsRNA-Leu-AAG, and tsRNA-Lys-CTT—as biomarkers for the diagnosis of diffuse large B-cell lymphoma. ROC analysis revealed that among these six tsRNAs, tsRNA-Leu-AAG had the highest AUC of 0.83.
[0005] Currently, the screening of rapid detection markers for diffuse large B-cell lymphoma mainly focuses on genes or proteins. Gut microbiota also plays an important role in the development of various tumors, but there is still a lack of systematic research on gut microbiota to use it to construct non-invasive diagnostic tools for DLBCL. Summary of the Invention
[0006] The purpose of this invention is to provide the application of reagents for detecting gut microbiota in the preparation of diagnostic or staging kits for diffuse large B-cell lymphoma (DLBCL), thus providing a new and effective approach for the early and rapid diagnosis or staging of DLBCL.
[0007] To achieve the above-mentioned objectives, the technical solution of the present invention is as follows: This invention first provides the application of reagents for detecting gut microbiota in the preparation of a staging kit for diffuse large B-cell lymphoma, wherein the gut microbiota includes short-chain fatty acid-producing bacteria, Enterococcus species, Helicobacter species, Yeast species, and pathogenic fungi; The reagents described above are used to detect the species abundance of gut microbiota.
[0008] This invention has revealed that the gut microbiota of DLBCL patients exhibits significant dynamic evolution from the healthy stage to the late stage of the disease, with its core feature being the disruptive reconstruction of the interaction network between short-chain fatty acid-producing bacteria (i.e., SCFA-producing bacteria) and fungi. During the healthy phase, the microbial interaction network is dominated by weak cross-domain mutualism between short-chain fatty acid-producing bacteria and yeast species (R=0.71-0.85). The strong short-chain fatty acid production capacity of short-chain fatty acid-producing bacteria can inhibit fungal pathogenicity. However, as DLBCL progresses, a pathogenic symbiotic network dominated by enterococcal and spirobacterial species gradually forms. The short-chain fatty acid production capacity of short-chain fatty acid-producing bacteria gradually weakens, and the mutualism with yeast species breaks down. This leads to the synergistic expansion of enterococcal, spirobacterial, and pathogenic fungi. In the late stage of DLBCL, enterococcal and spirobacterial species form a very strong cross-domain symbiotic axis with pathogenic fungi, and the function of short-chain fatty acid-producing bacteria is almost lost (Blautia<3%), revealing the irreversible transformation of the microbial community from metabolic homeostasis to a pro-inflammatory microenvironment.
[0009] As the disease progresses, the intensity of gut microbiota interactions (mean R value) increases from 0.82 in the healthy stage and 0.91 in the early stage to 0.97 in the late stage, with the number of network node connections doubling. This suggests that disease progression is accompanied by a contraction of the microbiota community structure and an increase in pathogenic synergy. From the healthy stage to the late stage of DLBCL, the core short-chain nucleotide-producing bacteria in the gut exhibit progressive depletion, while opportunistic pathogens gradually expand and form a closely associated pro-inflammatory module in Stage 3.4. This dynamic change reveals the collapse of gut ecological homeostasis during lymphoma progression. Therefore, by detecting the species abundance of the gut microbiota and analyzing the interaction intensity of various communities within the gut microbiota, a rapid and effective staging assessment of the disease course of diffuse large B-cell lymphoma in patients can be achieved.
[0010] Preferably, the short-chain fatty acid producing bacteria include species of the family Trichophyceae and species of the genus Ruminococcus. The pathogenic fungi mentioned include species of the genus Candida and species of the family Cryptococcus. 。
[0011] As a further preferred option, the species of the Trichophyceae family is derived from the Broutella genus.
[0012] This invention also provides the application of the above-mentioned reagent for detecting intestinal flora in the preparation of a diagnostic kit for diffuse large B-cell lymphoma. Preferably, the intestinal flora consists of the following bacterial species: *Corynebacterium harzianum*. Anaerotypes dust Enterococcus faecalis Enterococcus faecium Eubacterium Eubacterium sp. CAG_76, Broutella Blautia sp.CAG_37, uncultured Broutella strain uncultured Blautia_sp Rumenococcus Ruminococcus sp. 5_1_39BFAA, Monomorphic giant cell bacterium Megamonas funicularis Rumenococcus Ruminococcus sp. CAG_9, Broutella Blautia sp. Marseille_P2398, Broutella Blueberry sp. CAG_237, Enterococcus faecalis Intestinal roseburia Rumenococcus Ruminococcus sp. A254_MGS_108, *E. rectum* Eubacterium rectale ; The reagents described above for measuring gut microbiota are used to detect the species abundance of gut microbiota.
[0013] The 13 key bacterial species variables mentioned above were screened from the aforementioned microbial interaction network. The diagnostic model constructed using these 13 key bacterial species as markers exhibited excellent discrimination efficacy. In the training cohort, the area under the receiver operating characteristic (ROC) curve (AUC) reached 0.982 (95% CI: 0.941), with sensitivity and specificity of 100% and 87.5%, respectively. In the validation cohort, the AUC was 0.961 (95% CI: 0.9181), with sensitivity and specificity of 87.5% and 97.2%, respectively. This indicates that the microbial community feature model demonstrated reliable diagnostic potential in both training and external validation, providing a microbiome-based basis for the non-invasive auxiliary diagnosis of DLBCL.
[0014] Compared with the prior art, the technical effects of the present invention are reflected in: (1) This study found that the gut microbiota of DLBCL patients exhibits significant dynamic evolution from the healthy stage to the late stage of the disease, with the core feature being the disruptive reconstruction of the interaction network between short-chain fatty acid-producing bacteria and fungi. As the disease progresses, the interaction strength of the gut microbiota (mean R value) increases from 0.82 in the healthy stage and 0.91 in the early stage to 0.97 in the late stage, and the number of network node connections doubles, indicating that disease progression is accompanied by a contraction of the microbiota community structure and an enhancement of pathogenic synergy. From the healthy stage to the late stage of DLBCL, the core SCFA-producing bacteria in the gut show progressive depletion, while opportunistic pathogens gradually expand and form a closely related pro-inflammatory module in Stage 3.4. This dynamic change reveals the collapse of gut ecological homeostasis during lymphoma progression. Therefore, by detecting the species abundance of the gut microbiota and analyzing the interaction strength of each community in the gut microbiota, the disease course of diffuse large B-cell lymphoma in patients can be rapidly and effectively staged, enabling large-scale screening and longitudinal disease monitoring.
[0015] (2) The 13 key bacterial species variables obtained by further screening from the above-mentioned microbial interaction network are: The diagnostic model constructed using these 13 key bacterial species as markers has excellent discrimination efficacy. The area under the receiver operating characteristic curve (ROC) (AUC) in the training cohort is 0.982 (95% CI: 0.941), with sensitivity and specificity of 100% and 87.5%, respectively; the AUC in the validation cohort is 0.961 (95% CI: 0.9181), with sensitivity and specificity of 87.5% and 97.2%, respectively. This indicates that the microbial community feature model shows reliable diagnostic potential in both training and external validation. It can significantly improve the early screening rate of DLBCL and can also be combined with existing treatment decision models to assist in prognostic judgment.
[0016] (3) This invention provides a microbiome basis for the non-invasive auxiliary diagnosis of DLBCL, enabling rapid screening, diagnosis or prognosis of the disease without the need for biopsy. Attached Figure Description
[0017] Figure 1 Spearman correlation analysis of gut microbiota at the phylum level with Simpson index and Shannon-Wiener diversity index; Here, Spearman's correlation represents Spearman's correlation. + * indicates FDR < 0.05, * indicates FDR < 0.01, ** indicates FDR < 0.001; Simpson index indicates Simpson index, Shannon-Weiner index indicates Shannon-Weiner index, Number of genes indicates total number of genes; Lentisphaerae indicates phylum Lentisphaerae; Candidatus indicates candidate phylum; Marine microbes Indicates the phylum Marine Microbes; Spirochaetes Indicates the phylum Spirochete; Haloplasmatales means Haloplasma order; Fibrobacteria Indicates the phylum Cercobacteria; Euryarchaeota Indicates the phylum Archaea; Ascomycota Indicates the phylum Ascomycota; Firmicutes This refers to the Firmicutes phylum; the same applies below. Figure 2 Spearman correlation analysis of gut microbiota at the genus level with Simpson index and Shannon-Wiener index; in, Piloderma Indicates the genus Leucobacterium; Propionimicrobium Indicates Propionibacterium genus; Homolaphlyctis Indicates the same genus as *Cypripedium*; Pisolith This refers to the genus *Puffball*. Candidatus_Entotheonella Indicates the genus *Smallaria* within the candidate genus; Mitosporidium It represents the genus *Firmi*. LeptographIt represents the genus *Myxocybe*. Mixed Indicates the genus *Mixed Sporozoa*; Sarocladium Indicates the genus *Zygophyllum*; Phialocephalus Indicates the genus *Bottlehead*; Tistrella Indicates the genus *Rhodotorula*; Acidomyces Indicates the genus *Acidophilus*; Aureobasidium Indicates the genus *Briestros*; Baudouinia Indicates the genus Bordeaux; Gravel Indicates the genus *Gynostemma*; Dothistroma Indicates the genus Coleopterus; Oidium Indicates the genus *Pyrrosia*; Basidiobolus Indicates the genus *Frog-dung mold*; Phyllophora Indicates the genus *Phyllostachys*; Hymenoscyphus Indicates the genus *Cyclocarya*; Nakaseomyces Indicates the genus *Nakamura*; Planococcus Indicates the genus *Aggregatibacter*; Virgibacillus Indicates the genus *Mycobacterium*; Ophiostoma Indicates the genus *Longiformis*; Escovopsis Indicates Escophyte genus; Sclerotinia Indicates the genus *Sclerotium*; Cellulophagous Indicates the genus *Fibrophagium*; Stomatobacillus Indicates the genus *Bacillus*. Coprococcus It represents the genus *Corynebacterium*. Intestinals Indicates Enteromonas genus; Pseudoflavonifer Indicates *Pseudomonas* genus; Golden Indicates Dornodella genus; Oxalobacter Indicates the genus *Oxalis*; Oscillibacter Indicates *Zygomyces* genus; Johnsonella Indicates the genus *Johnsonella*; Pelotomaculum It represents the genus Coleobacterium; Ruminiclostridium Indicates ruminosae genus; Bilophila Indicates the genus *Bacillus*; Desulfovibrio Indicates *Desulfovibrio* genus; Faecalibacterium Indicates the genus *Faecalibacterium*; Allobacillus Indicates *Isobacterium* genus; Brachyspira Indicates the genus *Short Spirochetes*; Spiroplasma Indicates the genus *Spiropus*; Mesoplasma Indicates the genus Mycoplasma; Pseudobutyrivibrio Indicates *Vibrio pseudobutyricum* genus; Paraprevotella Indicates *Parprevotella* genus; Candidate_Stoquefichus The candidate genus is Stokes. Acetavibrio Indicates Vibrio acetic acid; Christensenella Indicates the genus Christensenella; Lachnobacterium Indicates the genus *Trichoderma*; Enterocytozoon This indicates the genus Enterocytozoa (Note: Microsporidia). Anaerotrunc Indicates the genus *Bacteroides*. Anaerobic bacteria Indicates the genus *Halobacter*. Myroids Indicates the genus *Pseudomonas*; Collinsella Indicates Collins genus; Slack Indicates Slack bacteria; Weeksella Indicates the genus *Wexella*; Gorillibacterium Indicates the genus *Gorilla*; Enterorhabdus Indicates Enterobacteriaceae; Senegalmassilia This refers to the genus *Massilia* from Senegal. Robinsonella Indicates the genus Robinsonii; Blueberry Indicates Broutella genus; Faecalitale It represents the genus *Fragaria*. Marvinbryantia Indicates the genus *Brucella martensii*; Lachnospira Indicates the genus *Trichophyton*; Butyricimonas It refers to the genus *Butymonas*. Laceyella Indicates Reissella genus; Huge Indicates the genus *Gastromyxophytes*; Variegated stick Indicates the genus *Proteobacterium*; Butyrivibrio Indicates Vibrio butyricum; Eubacterium It represents the genus *Eubacterium*; *Treponema* represents the genus *Treponema*. Sharpe Indicates the genus *Charis*; Clostridium Indicates the genus Clostridium; Oribacterium This refers to the genus *Bacillus* (Note: compared to...). Stomatobacillus different); Mobile Indicates the genus *Moscovite*; Subdoligranule Indicates the genus *Lysimachia*; Holdemanella Indicates Holmanella genus; Levyella Indicates the genus *Leyvetiraceae*; Rosemary Indicates *Rochetomyces* genus; Bacteroides_pectinophilus Indicates Bacteroides pectinophilus; Heliobacterium Indicates the genus *Syntrophus*; Ruminococcus Indicates Rumenococcus spp.; Butyricococcus Indicates *Butyrica spp.* Hold'em Indicates the genus *Holdmans*; Selenomonas Indicates the genus *Lysimachia*; Figure 3 Gut microbiota characteristics at the phylum level in healthy individuals and newly diagnosed DLBCL patients; in, Ascomycota Indicates the phylum Ascomycota; Haloplasmatales means Haloplasma order; Euryarchaeota Indicates the phylum Archaea; Choanozoa This indicates the phylum Collegiformes; Spirochaetes Indicates the phylum Spirochete; Fibrobacterota Indicates the phylum Cercobacteria; Bacteria -LF-3 indicates bacteria -LF3; Bacteria -MS4 indicates bacteria -MS4; Bacteria -OL-1 indicates bacteria -OL1; Bacteria -SIT5 indicates bacteria -SIT5; Figure 4 Gut microbiota characteristics at the genus level in healthy individuals and newly diagnosed DLBCL patients; Where Group represents the group, HC represents the healthy population, and Pre represents newly diagnosed DLBCL patients; the vertical axis log10 (Relative Abundance) represents the relative abundance after logarithmic transformation; Blueberry Indicates Broutella genus; Enterococcus Indicates Enterococcus spp.; Eubacterium Indicates the genus *Eubacterium*; Clostridium Indicates the genus Clostridium; Rosemary Indicates *Rochetomyces* genus; Faecalibacterium Indicates the genus *Faecalibacterium*; Lactobacillus Indicates Lactobacillus genus; Ruminococcus Indicates Rumenococcus spp.; Golden Indicates Dornodella genus; Coprococcus This refers to the genus *Factococcus*; the same applies below. Figure 5 The gut microbiota characteristics at the species level in healthy individuals and newly diagnosed DLBCL patients; in, Enterococcus_faecium Indicates Enterococcus faecalis; Faecalibacterium_prausnitzii Indicates Clostridium plasminoides; Blautia_sp_ CAG_37 indicates the CAG_37 strain of Broutella; Blautia_wexlerae Indicates Wexlerbroutella; Eubacterium_rectale Indicates rectal eubacterium; uncultured_Faecalibacterium_ sp This indicates that no *Faecalibacterium* species were cultured. Roseburia_sp_ CAG_18 indicates the CAG_18 strain of Rosella dysenteriae; Ruminococcus_sp_ CAG_108 indicates the CAG_108 strain of Ruminococcus; Ruminococcus_sp_ 5_1_39BFAA represents the 5_1_39BFAA strain of Ruminococcus; Ruminococcus_sp_ CAG_9 indicates the CAG_9 strain of Ruminococcus; Ruminococcus_sp_ A254_MGS_108 represents the Ruminococcus strain A254_MGS_108; Blautia_sp_ Marseille_P2398 indicates the Marseille P2398 strain of Broutella marsé. Roseburia_faeces Indicates fecal Rosella; Ruminococcus_bromii Indicates brominated rumenococci; Bacteroides_coprocola Indicates Bacteroides fecalith; Bacteroides_plebeius_ CAG_211 indicates the Bacteroides cibarius strain CAG_211; Ruminococcus_torques Indicates *Ruminococcus twitchis*; Dorea_longicatena Indicates long-chain Dorperella; Intestinal_roseburia Indicates *Rossiella pneumoniae* in the intestines; Anaerostipes_hadrus This refers to *Clostridium halys*, an anaerobic bacterium. Figure 6 Principal component analysis of gut microbiota at the phylum level for healthy individuals, newly diagnosed early-stage DLBCL patients, and newly diagnosed late-stage DLBCL patients. Wherein, PCoA represents principal component analysis, Pcoa by distance of bray between samples represents principal coordinate analysis between samples based on Bray-Curtis distance, Stage 12 represents early-stage DLBCL patients, Stage 34 represents late-stage DLBCL patients, and Adonis test represents permutation multivariate analysis of variance. Figure 7 Principal component analysis of gut microbiota at the genus level for healthy individuals, newly diagnosed early-stage DLBCL patients, and newly diagnosed late-stage DLBCL patients. Figure 8 Principal component analysis of gut microbiota at the species level for healthy individuals, newly diagnosed early-stage DLBCL patients, and newly diagnosed late-stage DLBCL patients. Figure 9 A heatmap showing the differences in 59 gut microbiota between healthy individuals and newly diagnosed DLBCL patients; in, Acinetobacter_sp_ CAG_196 represents Acinetobacter CAG_196 strain; Anaerotruncus_ sp_ G3_2012 represents the anaerobic truncate bacterium strain G3_2012; Bacillaceae_bacterium_ mt6 represents the bacterium mt6 of the Bacillus family; Bacteroides_pectinophilus Indicates Bacteroides pectinophilus; Blautia_sp_ CAG_37 indicates the CAG_37 strain of Broutella; Blautia_sp_ KLE_1732 indicates the Broutella KLE_1732 strain; Blautia_sp_ Marseille_P2398 indicates the Marseille P2398 strain of Broutella marsé. Blautia_wexlerae Indicates Wexlerbroutella; Butyrivibrio_crossotus Indicates Vibrio ruminantis; Butyrivibrio_proteoclasticus Indicates Vibrio butyricum; Butyrivibrio_sp_ AE3003 indicates Vibrio butyricum strain AE3003; Butyrivibrio_sp_ CAG_318 indicates the CAG_318 strain of Vibrio butyricum; Butyrivibrio_sp_ WCE2006 represents Butyricovibrio strain WCE2006; Christensenella_sp_ Marseille_P2437 indicates the Marseille P2437 strain of Christensenella; Clostridiales_bacterium_ CHKCI001 represents the bacterium CHKCI001 of the order Clostridium; Clostridiales_ bacteria_KLE1615 indicates the bacterium KLE1615 of the order Clostridium; Clostridium_sp_ 12_A represents Clostridium 12 A strain; Clostridium_sp_ CAG_122 indicates the Clostridium CAG_122 strain; Clostridium_sp_ CAG_264 indicates the Clostridium CAG_264 strain; Clostridium_sp_ CAG_356 indicates the Clostridium CAG_356 strain; Clostridium_sp_ CAG_62 indicates the Clostridium CAG_62 strain; Clostridium_sp_ L2_50 indicates Clostridium L2 50 strain; Clostridium_sp_ SY8519 indicates the Clostridium SY8519 strain; Coprococcus_eutactus It represents coccidioidomyces; Coprococcus_sp_ ART55_1 indicates the ART55 1 strain of *Coccobacillus faecalis*. Dorea_sp_ 5_2 indicates Dornos bacteria strain 52; Eubacterium_siraeum_ CAG_80 represents the CAG_80 strain of Filamentous Eubacterium; Eubacterium_sp_ CAG_252 indicates the CAG_252 strain of Eubacterium; Eubacterium_sp_ CAG_274 indicates the CAG_274 strain of Eubacterium; Eubacterium_sp_ CAG_86 indicates the CAG_86 strain of Eubacterium; Eubacterium_xylanophilum Indicates xylanophilic eubacterium; Firmicutes_bacterium _ASF500 indicates the ASF500 of Firmicutes bacteria; Firmicutes_bacterium_ CAG_227 represents the Firmicutes bacteria CAG_227; Firmicutes_bacterium_ CAG_882 represents Firmicutes bacteria CAG_882; Heliobacterium_sp_ N15_MGS_306 indicates the N15 MGS 306 strain of *Bacillus scintillans*. Laceyella_sacchari Indicates sugarcane crown fungus; Lachnospira_multipara It represents Spirulina multibranchii; Lachnospiraceae_bacterium_ 10_1 represents 10 1 of the bacteria in the family Spirulinaceae; Lachnospiraceae_bacterium_ 28_4 indicates that the bacteria in the family Spirulinaceae is 28 4; Lachnospiraceae_bacterium_ A4 represents bacteria A4 of the family Spirulinaceae; Lachnospiraceae_bacterium_ AC2012 represents bacteria of the family Spirulinaceae, AC2012. Lachnospiraceae_bacterium _MD2004 represents the bacteria MD2004 of the family Spirulinaceae; Lachnospiraceae_bacterium _NK4A136 represents the bacteria NK4A136 of the family Spirulinaceae; Lactobacillus_sp_ N15_MGS_260 indicates Lactobacillus strain N15 MGS 260; Megasphaera_sp_ MJR9396C represents the MJR9396C strain of Macrococcus; Prevotella_sp_ CAG_485 indicates the CAG_485 strain of Prevotella; Pseudobutyrivibrioruminis Indicates *Vibrio ruminantis*; Robinsoniella_peoriensis Indicates Peoria Robinsonii; Roseburia_sp_ CAG_303 indicates the CAG_303 strain of Rosella dysenteriae; Roseburia_sp_ CAG_309 indicates the CAG_309 strain of Rosella dysenteriae; Roseburia_sp_ CAG_380 indicates the CAG_380 strain of Rosella dysenteriae; Roseburia_sp_ UNK_MGS_15 indicates the UNK MGS 15 strain of Rosella esculenta; Ruminococcus_sp_ CAG_9 indicates the CAG_9 strain of Ruminococcus; Ruminococcus_sp_ FC2018 indicates the FC2018 strain of Rumenococcus; Streptococcus_ dysgalactia Indicates Streptococcus lactis; Thermoactinomyces_vulgaris This refers to common thermophilic actinomycetes; uncultured_Blautia_sp This indicates that no Brontë strains were cultured; uncultured_Lachnospira_sp This indicates an uncultured *Tricholoma matsutake* strain; Varibaculum_cambriense Indicates Welsh bacillus; Figure 10 A heatmap showing the differences in 33 gut microbiota between healthy individuals and newly diagnosed DLBCL patients; in, Streptomyces_alboniger Indicates white and black Streptomyces; Candida_dubliniensis Indicates Candida dublinii; Candida_orthopsilosis Indicates a perfectly round Candida; Candida_sp_ LDI48194 indicates the LDI48194 strain of Candida albicans; Candida tropicalis Indicates tropical Candida; Capronia_epimyces Indicates *Calpromella epidermoides*; Lodderomyces_elongisporus Indicates *Lycorydalis longissimus*; Candida_glabrata Indicates Candida glabrata; Candida_boidinii Indicates Candida botrytis; Parastagonospora_nodorum Indicates *Symplocosus spp.*; Spathaspora_arboraria Indicates *Spirospermum spp.* (forest yeast); Spathaspora_passalidarum Indicates *Spirospermum praecox*; Baltic_cellophaga This refers to Baltic fibroblasts; Cryptococcus_laurentii This refers to *Cryptococcus laurigenans*. Cryptococcus_neoformans Indicates Cryptococcus neoformans; Tremella fuciformis It refers to white fungus; Trichosporon_asahii It refers to Trichosporium azadirachtinum; Bacillaceae_bacterium_ MTCC_8252 indicates that the bacteria belongs to the Bacillus family, MTCC 8252. Candidatus_Clostridium_anorexicamassiliense Indicates candidate anaerobic Clostridium; Enterococcus_canis Indicates Enterococcus canis; Enterococcus_faecium Indicates Enterococcus faecalis; Enterococcus_hirae Indicates Enterococcus haematobacterium; Enterococcus_mundtii Indicates Enterococcus montelukastii; Enterococcus_sp_ GMD1E represents enterococcal GMD1E strain; Enterococcus_sp _GMD2E indicates Enterococcus GMD2E strain; Enterococcus_sp_ GMD3E represents enterococcal GMD3E strain; Enterococcus_sp_ GMD4E indicates the Enterococcus GMD4E strain; Enterococcus_sp_ GMD5E represents enterococcal GMD5E strain; Lactobacillus_antri Indicates Lactobacillus antrum; Lactobacillus_murinus Indicates Lactobacillus murineis; Planococcus_plakortidis Indicates Pracotyl; Helicobacter_heilmannii Indicates Helicobacter niger; Pseudovibrio_sp_ Ad37 represents Pseudovibrio strain Ad37; Figure 11 For the gut microbiota interaction network of healthy individuals; in, Candida_boidinii Indicates Candida botrytis; Candida_dubliniensis Indicates Candida dublinii; Candida_glabrata Indicates Candida glabrata; Candida_orthopsilosis Indicates a perfectly round Candida; Candida_sp_ LDI48194 indicates the LDI48194 strain of Candida albicans; Candida tropicalis Indicates tropical Candida; Candidatus_Clostridium_anorexicamassiliense Indicates candidate anaerobic Clostridium; Capronia_epimyces Indicates *Calpromella epidermoides*; Baltic_cellophaga This refers to Baltic fibroblasts; Enterococcus_canis Indicates Enterococcus canis; Enterococcus_faecium Indicates Enterococcus faecalis; Enterococcus_mundtii Indicates Enterococcus montelukastii; Enterococcus_sp_ GMD1E represents enterococcal GMD1E strain; Enterococcus_sp_ GMD2E represents enterococcal GMD2E strain; Enterococcus_sp_ GMD3E represents enterococcal GMD3E strain; Enterococcus_sp_ GMD4E indicates the Enterococcus GMD4E strain; Enterococcus_sp_ GMD5E represents enterococcal GMD5E strain; Helicobacter_ Heilmann's Indicates Helicobacter niger; Lodderomyces_elongisporus Indicates *Lycorydalis longissimus*; Parastagonospora_nodorum Indicates *Symplocosus spp.*; Pseudovibrio_sp_ Ad37 represents Pseudovibrio strain Ad37; Spathaspora_arboraria Indicates *Spirospermum spp.* (forest yeast); Spathaspora_passalidarum Indicates *Spirospermum praecox*; Acinetobacter_sp_ CAG_196 indicates Acinetobacter CAG 196 strain; Bacteroides_ pectinophile Indicates Bacteroides pectinophilus; Blautia_sp_KLE_1732 indicates the Brontë strain KLE 1732; Blautia_sp_ Marseille_P2398 indicates the Marseille P2398 strain of Broutella marsé. Blautia_wexlerae Indicates Wexlerbroutella; Butyrivibrio_proteoclasticus Indicates Vibrio butyricum; Butyrivibrio_ sp_ CAG_318 indicates the CAG 318 strain of Vibrio butyricum; Butyrivibrio_sp_ WCE2006 represents Butyricovibrio strain WCE2006; Clostridiales_bacterium_ KLE1615 indicates the bacterium KLE1615 of the order Clostridium; Clostridium_sp_ CAG_122 indicates the Clostridium CAG 122 strain; Clostridium_sp_ CAG_62 indicates the Clostridium CAG 62 strain; Clostridium_ sp_ L2_50 indicates Clostridium L2 50 strain; Clostridium_sp_ SY8519 indicates the Clostridium SY8519 strain; Eubacterium_siraeum_ CAG_80 indicates the CAG 80 strain of filamentous eubacterium; Eubacterium_sp_ CAG_86 indicates the CAG 86 strain of *Eubacterium*. Firmicutes_bacterium_ CAG_882 represents the CAG 882 strain of Firmicutes bacteria; Laceyella_sacchari Indicates sugarcane crown fungus; Lachnospira_multipara It represents Spirulina multibranchii; Lachnospiraceae_bacterium_ 10_1 represents 10 1 of the bacteria in the family Spirulinaceae; Lachnospiraceae_ bacteria_ 28_4 indicates that the bacteria in the family Spirulinaceae is 28 4; Lachnospiraceae_bacterium_ AC2012 represents bacteria of the family Spirulinaceae, AC2012. Lachnospiraceae_bacterium_ NK4A136 represents the bacteria NK4A136 of the family Spirulinaceae; Lactobacillus_sp_ N15_MGS_260 indicates Lactobacillus strain N15 MGS 260; Prevotella_sp_ CAG_485 indicates Prevotella CAG 485 strain. In this context, red nodes represent species that consistently decline, and blue nodes represent species that consistently increase, with a correlation p-fdr < 0.001, and the same applies below; Figure 12 A gut microbiota interaction network for newly diagnosed early-stage DLBCL patients; in, Bacillaceae_bacterium_ MTCC_8252 indicates that the bacteria belongs to the Bacillus family, MTCC 8252. Candida_boidinii Indicates Candida botrytis; Candida_dubliniensis Indicates Candida dublinii; Candida_glabrata Indicates Candida glabrata; Candida_orthopsilosisIndicates a perfectly round Candida; Candida_ sp_ LDI48194 indicates the LDI48194 strain of Candida albicans; Candida tropicalis Indicates tropical Candida; Candidatus_Clostridium_anorexicamassiliense Indicates candidate anaerobic Clostridium; Capronia_epimyces Indicates *Calpromella epidermoides*; Baltic_cellophaga This refers to Baltic fibroblasts; Cryptococcus_ Lawrence This refers to *Cryptococcus laurigenans*. Cryptococcus_neoformans Indicates Cryptococcus neoformans; Enterococcus_ dog Indicates Enterococcus canis; Enterococcus_faecium Indicates Enterococcus faecalis; Enterococcus_hirae Indicates Enterococcus haematobacterium; Enterococcus_mundtii Indicates Enterococcus montelukastii; Enterococcus_sp_ GMD1E represents enterococcal GMD1E strain; Enterococcus_sp_ GMD2E represents enterococcal GMD2E strain; Enterococcus_sp_ GMD3E represents enterococcal GMD3E strain; Enterococcus_sp_ GMD4E indicates the Enterococcus GMD4E strain; Enterococcus_sp_ GMD5E represents enterococcal GMD5E strain; Helicobacter_heilmannii Indicates Helicobacter niger; Lactobacillus_ mouse Indicates Lactobacillus murineis; Lodderomyces_elongisporus Indicates *Lycorydalis longissimus*; Pseudovibrio_ sp_ Ad37 represents Pseudovibrio strain Ad37; Spathaspora_arboraria Indicates *Spirospermum spp.* (forest yeast); Tremella_ fusiform It refers to white fungus; Trichosporon_asahii It refers to Trichosporium azadirachtinum; Anaerotruncus_sp_ G3_2012 indicates the G3 2012 strain of anaerobic Corynebacterium; Bacteroides_pectinophilus Indicates Bacteroides pectinophilus; Blautia_sp_ KLE_1732 indicates the Brontë strain KLE 1732; Blautia_sp_ Marseille_P2398 indicates the Marseille P2398 strain of Broutella marsé. Blautia_wexlerae Indicates Wexlerbroutella; Butyrivibrio_ cross-legged Indicates *Vibrio curvularis*; Butyrivibrio_proteoclasticus Indicates Vibrio butyricum; Butyrivibrio_sp_ WCE2006 represents Butyricovibrio strain WCE2006; Clostridiales_bacterium_ KLE1615 indicates the bacterium KLE1615 of the order Clostridium; Clostridium_sp_ CAG_264 indicates the Clostridium CAG 264 strain; Clostridium_sp_CAG_62 indicates the Clostridium CAG 62 strain; Clostridium_sp_ L2_50 indicates Clostridium L2 50 strain; Clostridium_sp_ SY8519 indicates the Clostridium SY8519 strain; Coprococcus_eutactus This indicates true foetida; Coprococcus_sp_ ART55_1 indicates the ART55 1 strain of *Coccobacillus faecalis*. Dorea_sp_ 5_2 indicates Dornos bacteria strain 52; Eubacterium_siraeum_ CAG_80 indicates the CAG 80 strain of filamentous eubacterium; Eubacterium_sp_ CAG_252 indicates the CAG 252 strain of Eubacterium; Firmicutes_bacterium_ CAG_882 represents the CAG 882 strain of Firmicutes bacteria; Laceyella_sacchari Indicates sugarcane crown fungus; Lachnospiraceae_bacterium_ 10_1 represents 10 1 of the bacteria in the family Spirulinaceae; Lachnospiraceae_bacterium_ 28_4 indicates that the bacteria in the family Spirulinaceae is 28 4; Lachnospiraceae_bacterium_ A4 represents bacteria A4 of the family Spirulinaceae; Lachnospiraceae_bacterium_ AC2012 represents bacteria of the family Spirulinaceae, AC2012. Lachnospiraceae_bacterium_ MD2004 represents the bacteria MD2004 of the family Spirulinaceae. Roseburia_sp_ UNK_MGS_15 indicates the UNK MGS 15 strain of Rosella esculenta; Ruminococcus_sp_ CAG_9 indicates the CAG 9 strain of Ruminococcus; Streptococcus_dysgalactiae Indicates Streptococcus lactis; Varibaculum_cambriense Indicates Cambrian rod-shaped bacteria; Figure 13 A gut microbiota interaction network for newly diagnosed advanced DLBCL patients; in, Bacillaceae_bacterium_ MTCC_8252 indicates that the bacteria of the Bacillus family is MTCC 8252. Candida_boidinii Indicates Candida botrytis; Candida_dubliniensis Indicates Candida dublinii; Candida_glabrata Indicates Candida glabrata; Candida_orthopsilosis Indicates a perfectly round Candida; Candida_ sp_ LDI48194 indicates the LDI48194 strain of Candida albicans; Candida tropicalis Indicates tropical Candida; Candidatus_Clostridium_anorexicamassiliense Indicates candidate anaerobic Clostridium; Capronia_ epimyces Indicates *Calpromella epidermoides*; Baltic_cellophaga This refers to Baltic fibroblasts; Cryptococcus_laurentii This refers to *Cryptococcus laurigenans*. Cryptococcus_neoformans Indicates Cryptococcus neoformans; Enterococcus_canis Indicates Enterococcus canis; Enterococcus_faeciumIndicates Enterococcus faecalis; Enterococcus_hirae Indicates Enterococcus haematobacterium; Enterococcus_mundtii Indicates Enterococcus montelukastii; Enterococcus_sp_ GMD1E represents enterococcal GMD1E strain; Enterococcus_sp_ GMD2E represents enterococcal GMD2E strain; Enterococcus_sp_ GMD3E represents enterococcal GMD3E strain; Enterococcus_sp_ GMD4E indicates the Enterococcus GMD4E strain; Enterococcus_sp_ GMD5E represents enterococcal GMD5E strain; Helicobacter_ Heilmann's Indicates Helicobacter niger; Lactobacillus_murinus Indicates Lactobacillus murineis; Lodderomyces_ long-spore Indicates *Lycorydalis longissimus*; Parastagonospora_nodorum Indicates *Symplocosus spp.*; Planococcus_plakortidis Indicates *Platycodactylus*; Spathaspora_arboraria Indicates *Spirospermum spp.* (forest yeast); Spathaspora_passalidarum Indicates *Spirospermum praecox*; Streptomyces_alboniger Indicates white and black Streptomyces; Tremella fuciformis It refers to white fungus; Acinetobacter_sp_ CAG_196 indicates Acinetobacter CAG 196 strain; Anaerotruncus_sp_ G3_2012 indicates the G3 2012 strain of anaerobic Corynebacterium; Bacillaceae_ bacteria_ mt6 represents the bacteria mt6 of the Bacillus family; Bacteroides_pectinophilus Indicates Bacteroides pectinophilus; Blautia_sp_ CAG_37 indicates the CAG 37 strain of Broutella. Blautia_sp_ KLE_1732 indicates the Brontë strain KLE 1732; Blautia_sp _Marseille_P2398 indicates the Marseille strain P2398 of Broutbacterium. Blautia_wexlerae Indicates Wexlerbroutella; Butyrivibrio_crossotus Indicates *Vibrio curvularis*; Butyrivibrio_proteoclasticus Indicates Vibrio butyricum; Butyrivibrio_sp_ AE3003 indicates Vibrio butyricum strain AE3003; Butyrivibrio_sp_ CAG_318 indicates Vibrio butyricum strain CAG 318; Butyrivibrio_sp_ WCE2006 represents Butyricovibrio strain WCE2006; Clostridiales_bacterium_ CHKCI001 represents the bacterium CHKCI001 of the order Clostridium; Clostridiales_bacterium_ KLE1615 indicates the Clostridium order bacteria KLE1615; Clostridium_sp_ 12_A represents Clostridium 12 A strain; Clostridium_sp_CAG_122 indicates the Clostridium CAG 122 strain; Clostridium_sp_ CAG_264 indicates Clostridium CAG 264 strain; Clostridium_sp_ CAG_356 indicates Clostridium CAG 356 strain; Clostridium_sp_ CAG_62 indicates the Clostridium CAG 62 strain; Clostridium_ sp_ L2_50 indicates Clostridium strain L2 50; Clostridium_sp_ SY8519 indicates the Clostridium SY8519 strain; Coprococcus_eutactus This indicates true foetida; Coprococcus_sp_ ART55_1 indicates the ART55 1 strain of *Coccobacillus faecalis*. Dorea_sp_ 5_2 indicates Dornos bacteria strain 52; Eubacterium_sp_ CAG_86 indicates the CAG 86 strain of Eubacterium; Eubacterium_xylanophilum Indicates xylanophilic eubacterium; Firmicutes_bacterium_ ASF500 indicates the ASF500 of Firmicutes bacteria; Figure 14 Curve selection based on cross-validation; Where Number of variables represents the number of variables, and CV Error represents the cross-validation error; Figure 15 Ranking the importance of 13 key bacterial species variables; Where Mean Decrease Accuracy represents the average decrease in accuracy, and Mean Decrease Gini represents the average decrease in Gini. Anaerostipes hadrus Indicates *Haplospora harzianum*; Enterococcus faecium Indicates Enterococcus faecalis; Eubacterium_sp_ CAG 76 indicates the CAG 76 strain of the genus *Eubacterium*. Blautia sp. CAG 37 indicates the CAG 37 strain of the genus Broutella; uncultured Blautia sp. This indicates an uncultured population of the genus *Broutella*. Ruminococcus sp 5 1 39BFAA indicates the genus *Ruminococcus* sp5_1_39BFAA strain; Megamonas funiformis It refers to filamentous megamonas; Ruminococcus sp CAG 9 indicates the CAG 9 strain of Ruminococcus genus; Blautia_sp_ Marseile P2398 represents the Marseille-P2398 strain of the Brouteria genus; Blautia sp CAG 237 indicates the CAG 237 strain of the genus *Brutella*. Roseburia intestinalis Indicates Enterococcus faecium; Ruminococcus spA254 MGS 108 indicates the A254_MGS_108 strain of Ruminococcus spp.; Eubacterium rectale Indicates rectal eubacterium; Figure 16 The ROC curve for the training queue; Specificity represents specificity, Sensitivity represents sensitivity, and AUC represents the area under the curve, and the same applies below; Figure 17 To verify the ROC curve of the queue. Detailed Implementation
[0018] The technical solution of the present invention will be further described in detail below with reference to the accompanying drawings and embodiments.
[0019] 1. Sample collection and microbial sequencing Fecal samples were collected from newly diagnosed DLBCL patients (19 patients in stage 1.2 and 21 patients in stage 3.4) and healthy individuals (40 people). 16S rRNA and metagenomic sequencing technologies were used to obtain microbiome data at the phylum, genus and species levels in the samples.
[0020] 2. Diversity and taxonomic analysis The correlation between the Shannon-Wiener index and microbial community classification was analyzed, and the results are as follows: Figure 1 and Figure 2 As shown.
[0021] from Figure 1 It can be seen that, at the phylum level, Firmicutes... Firmicutes It had a negative impact on the Shannon-micro-nano diversity index (P<0.05), while the other bacteria had no statistically significant impact on the Shannon-micro-nano diversity index.
[0022] from Figure 2 It can be seen that among the 84 microbial diversity contributors screened at the genus level (P<0.05), 58 genera were positive, including 14 taxa that produce butyric acid or are related to butyric acid metabolism, such as... Coprococcus , Intestinimonas , Pseudoflavonifractor , Dorea , Faecalibacterium , Butyricimonas , Butyrivibrio , Eubacterium , Ruminococcus , Clostridium , Lachnospira , Roseburia , AnaerotruncuThese results demonstrate a substantial change in the components associated with the pathogenesis of DLBCL, which is also confirmed by taxonomic classification (see...). Figure 3 , Figure 4 and Figure 5 ).
[0023] 3. Stage-specific microbial community structure To analyze the stage-specific microbiota patterns of DLBCL, DLBCL patients were divided into Stage 1 / 2 and Stage 3 / 4 according to the Ann Arbor staging criteria, and gut microbiota interaction networks were established for the three groups (HC, Stage 1-2, and Stage 3-4).
[0024] Figure 6 , Figure 7 and Figure 8 The principal coordinate analysis results show that there are no significant differences in gut microbiota structure between healthy individuals and individuals in the combined stages (stage 1.2 and stage 3.4) at the phylum and genus levels. At the species level, there are significant differences between HC and the two stages, while no significant differences are found between the two combined stages.
[0025] Then, by using linear discriminant analysis of effect sizes, stage-specific classification differences were captured. For example... Figure 9 and Figure 10 As shown, the relative abundance of species was compared among HC, stage 1.2, and stage 3.4. Significant differences were found in the relative abundance of species between healthy individuals and stage 1.2, and between healthy individuals and stage 3.4 (microbial community fdr < 0.01). Species exhibiting similar trends across the three stages were then identified, including 33 consistently upregulated species (see [link to study]). Figure 10 ) and 59 species that were consistently downgraded (see Figure 9 ).
[0026] The species that were consistently upgraded mainly include Ascomycota ( Ascomycota Basidiomycota ( Basidiomycota Firmicutes ( Firmicutes Proteobacteria ( Proteobacteria ), of which yeasts ( Saccharomycetaceae ), Tremellaceae ( Tremellaceae Enterococci ( Enterococcaceae The main species downgraded were Firmicutes ( ). Firmicutes Proteobacteria ( Proteobacteria Bacteroidetes ( Bacteroidetes Proteobacteria ( Proteobacteria ), of which the family Trichophyceae ( Lachnospiraceae Clostridium (Clostridiaceae These species, primarily those that may play a core role in the evolution of diseases, are likely to change.
[0027] 4. Phased construction of microbial networks This embodiment constructed gut microbiota interaction networks for healthy controls (HC) and early (Stages 1-2) and late (Stages 3-4) diffuse large B-cell lymphoma (DLBCL) patients using Spearman correlation analysis based on species abundance. Network nodes were selected based on an FDR-corrected p-value <0.001. Results are as follows... Figure 11 , Figure 12 and Figure 13 As shown.
[0028] It can be seen that the gut microbiota of DLBCL patients exhibits significant dynamic evolution from the healthy stage to the late stage of the disease, with its core feature being the disruptive reconstruction of the interaction network between short-chain fatty acid-producing bacteria and pathogenic bacteria-fungi. In the healthy stage, the gut microbiota is dominated by Trichophytonceae. Lachnospiraceae (e.g., Blautia spp.), Rumenaceae family Ruminococcus (Main producer of butyrate) and yeasts ( Saccharomycetaceae The cross-domain weak mutualism of Enterococci (R=0.71-0.85) predominates, inhibiting fungal pathogenicity; as the disease progresses, Enterococci ( Enterococcaceae ) and Helicobacteraceae ( Helicobacteraceae A pathogenic symbiotic network dominated by short-chain fatty acid-producing bacteria gradually formed, weakening the interaction between these bacteria and other bacterial species, and breaking the mutualistic relationship with yeast. Instead, they interacted with pathogenic fungi (such as Candida). Candida Cryptococcidae Tremellaceae Synergistic expansion; in the late stage, pathogenic bacteria and fungi form a very strong cross-kingdom symbiotic axis (such as Cryptococcus-Enterococcus family R>0.99), and the function of short-chain fatty acid producing bacteria is almost lost (Blautia<3%), revealing the irreversible transformation of the microbiome from metabolic homeostasis to a pro-inflammatory microenvironment.
[0029] As the disease progresses, the intensity of gut microbiota interactions (mean R value) increases from 0.82 in the healthy stage and 0.91 in the early stage to 0.97 in the late stage, with the number of network node connections doubling. This suggests that disease progression is accompanied by a contraction of the gut microbiota community structure and an increase in pathogenic synergy. Therefore, from the healthy control group to the late stage of DLBCL, the core short-chain nucleotide-producing microbiota shows progressive depletion, while opportunistic pathogens gradually expand and form a closely associated pro-inflammatory module in Stage 3.4. This dynamic change reveals the collapse of gut ecological homeostasis during lymphoma progression. Therefore, by detecting the species abundance of the gut microbiota and analyzing the interaction intensity of various communities within the gut microbiota, a rapid and effective staging assessment of the disease course of diffuse large B-cell lymphoma in patients can be achieved.
[0030] 5. Screening of key bacterial strains and model construction A diagnostic model was constructed using a random forest algorithm combined with 10-fold cross-validation (500 decision trees, with 95% of features removed in each iteration). Finally, 13 key bacterial species variables were selected based on Mean Decrease Accuracy and the Gini index: *Clostridium perfringens*. Anaerostipes hadrus Enterococcus faecalis Enterococcus faecium Eubacterium Eubacterium sp. CAG_76, Broutella Blautia sp. CAG_37, uncultured Broutella strain uncultured Blautia_sp Rumenococcus Ruminococcus sp. 5_1_39BFAA, Monomorphic giant cell bacterium Megamonas funiformis Rumenococcus Ruminococcus sp. CAG_9, Broutella Blautia sp. Marseille_P2398, Broutella Blautia sp. CAG_237, Enterococcus faecalis Roseburia intestinalis Rumenococcus Ruminococcus sp. A254_MGS_108, *E. rectum* Eubacterium rectale ; Variable selection curves based on cross-validation are as follows Figure 14 As shown, the order of variable importance is as follows: Figure 15 As shown.
[0031] Using the collected fecal samples as a training cohort, the diagnostic efficacy of the diagnostic model was analyzed, and the results are as follows: Figure 16 As shown in the figure, the model demonstrates excellent discrimination performance in the training cohort, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.982 (95% CI: 0.941), and sensitivity and specificity of 100% and 87.5%, respectively.
[0032] Subsequently, this embodiment uses a metagenomics disclosed in a published article as a validation cohort to validate the above results. This validation cohort includes 106 newly diagnosed DLBCL patients, all of whom received R-CHOP treatment, and their gender and age are not significantly different from those of the aforementioned training cohort. Figure 17 The results showed that the AUC in the validation cohort was 0.961 (95% CI: 0.9181), with sensitivity and specificity of 87.5% and 97.2%, respectively.
[0033] The above experimental results all demonstrate that the diagnostic model exhibits reliable diagnostic potential in both training and external validation, providing a microbiome basis for the non-invasive auxiliary diagnosis of DLBCL.
Claims
1. The application of reagents for detecting gut microbiota in the preparation of a staging kit for diffuse large B-cell lymphoma, characterized in that, The gut microbiota includes short-chain fatty acid-producing bacteria, Enterococcus species, Helicobacter species, Yeast species, and pathogenic fungi; The reagents described above are used to detect the species abundance of gut microbiota.
2. The application as described in claim 1, characterized in that, The short-chain fatty acid producing bacteria include species from the family Trichophyceae and the genus Ruminococcus.
3. The application as described in claim 2, characterized in that, The aforementioned species of the Trichophyceae family originates from the Broutella genus.
4. The application as described in claim 1, characterized in that, The pathogenic fungi mentioned include species of the genus Candida and species of the family Cryptococcus. 。 5. The application of reagents for detecting intestinal flora in the preparation of diagnostic kits for diffuse large B-cell lymphoma, characterized in that, The gut microbiota includes short-chain fatty acid-producing bacteria, Enterococcus species, Helicobacter species, Yeast species, and pathogenic fungi; The reagents described above are used to detect the species abundance of gut microbiota.
6. The application as described in claim 5, characterized in that, The short-chain fatty acid producing bacteria include species from the family Trichophyceae and the genus Ruminococcus.
7. The application as described in claim 6, characterized in that, The aforementioned species of the Trichophyceae family originates from the Broutella genus.
8. The application as described in claim 7, characterized in that, The pathogenic fungi mentioned include species of the genus Candida and species of the family Cryptococcus. 。 9. The application as described in claim 5, characterized in that, The gut microbiota described consists of the following bacterial species: *Clostridium halys*. Anaerostipes hadrus Enterococcus faecalis Enterococcus faecium Eubacterium Eubacterium sp. CAG_76, Broutella Blautia sp. CAG_37, uncultured Broutella strain uncultured Blautia_sp Rumenococcus Ruminococcus sp. 5_1_39BFAA, Monomorphic giant cell bacterium Megamonas funiformis Rumenococcus Ruminococcus sp. CAG_9, Broutella Blautia sp. Marseille_P2398, Broutella Blautia sp. CAG_237, Enterococcus faecalis Roseburia intestinalis Rumenococcus Ruminococcus sp. A254_MGS_108, *E. rectum* Eubacterium rectale .
Citation Information
Patent Citations
Peripheral blood circRNA biomarker for diagnosing diffuse large B-cell lymphoma and application of peripheral blood circRNA biomarker
CN116622846A
TsRNA for predicting, diagnosing or monitoring diffuse large B-cell lymphoma, kit and application thereof
CN120624639A
